Where Will Amgen Be in 5 Years?
Can Amgen be a market-beating stock?
Want the Max $4,873 Social Security Benefit? Make Sure You Do These Two Things.
To receive the maximum benefit, you’ll need to reach earnings thresholds and delay benefits.
Is It Too Late to Buy Micron Stock?
Micron’s stock has surged, but is there still room for growth?
2 Artificial Intelligence (AI) Stocks That Could Go Parabolic
These stocks have jumped impressively following their latest earnings reports, and they could soar higher thanks to AI.
Despite dilution, officials say new nature law can restore EU carbon sinks
To meet climate goals, the European Union needs to reverse the decline of its carbon-storing ecosystems like forests and peatlands
The post Despite dilution, officials say new nature law can restore EU carbon sinks appeared first on Climate Home News.
Cathie Wood Discusses Bitcoin Live With Bitcoin Park’s Rod Roudi
In coordination with Bitcoin Park, ARK is pleased to introduce a monthly conversation with leaders in the Bitcoin space.
1 High-Flying Aerospace Stock to Buy Hand Over Fist and 1 to Avoid
Comparing these two high-profile aerospace-related companies highlights the stark difference in their operational performance.
Drugs for enlarged prostate may also protect against dementia with Lewy bodies
Certain drugs commonly used to treat enlarged prostate may also decrease the risk for dementia with Lewy bodies (DLB), according to a new study. The researchers think that a specific side effect of the drugs targets a biological flaw shared by DLB and …
Study finds one copy of protective genetic variant helps stave off early-onset Alzheimer’s disease
New research finds one copy of a protective genetic variant, APOE3 Christchurch, delayed onset of Alzheimer’s disease for 27 members of a ~6,000-person family in Colombia at high risk for early-onset Alzheimer’s in their 40s due to carrying the ‘Paisa’…
Combination targeted treatment produces lasting remissions in people with resistant aggressive B-cell lymphoma
Researchers have developed a non-chemotherapy treatment regimen that is achieving full remissions for some people with aggressive B-cell lymphoma that has come back or is no longer responding to standard treatments. The five-drug combination targets mu…